Home » Icagen, Pfizer Renew Deal on Pain Treatments
Icagen, Pfizer Renew Deal on Pain Treatments
Icagen Inc and Pfizer extended their worldwide collaboration and licensing deal for the second time through 2011, sending Icagen shares up 39 percent.
CNBC
CNBC
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May